96814 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses; RNA viruses; Togaviridae; Flaviviridae; Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus), border disease virus Hepatitis C; Hepatitis NANB
VSV VECTOR-ENCODED HCV ENVELOPE PROTEINS E1/E2 AS VACCINES AGAINST HEPATITIS C VIRUS
#2CHIMERIC ANTIGEN RECEPTOR (CAR) MODULATION
#3ASSEMBLED GLYCOPROTEINS
#4MODIFIED SECRETED HEPATITIS C VIRUS (HCV) E1E2 GLYCOPROTEINS AND METHODS OF USE THEREOF
#5HCV Recombinant Antigen and Application
#6Broad-spectrum anti-infective peptides
#7Chimeric antigen receptor (CAR) modulation
#8MODIFIED HEPATITIS C VIRUS E2 GLYCOPROTEINS AND METHODS OF USE THEREOF
#9Chimeric antigen receptor (CAR) modulation
#10BROAD-SPECTRUM ANTI-INFECTIVE PEPTIDES
#11Method for preparing multimeric forms of the hepatitis c virus (HCV) envelope glycoprotein 2 (HCV E2)
#12Broad-spectrum anti-infective peptides
#13Viral RNA segments as immunomodulatory agents and vaccine components
#14COMPOSITIONS AND METHODS FOR PREDICTING HCV SUSCEPTIBILITY TO ANTIVIRAL AGENTS
#15Modified Hepatitis C virus proteins
#16COMPOSITIONS AND METHODS THAT ENHANCE AN IMMUNE RESPONSE
#17Method for simultaneously detecting an antigen of, and an antibody, against, an infectious microorganism
#18Infectious hepatitis C virus—high producing HCV variants and use thereof
#19Compositions and methods that enhance an immune response
#20Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism